morning. for all this you Thank us joining
of across of million, million the quarter reflecting XXXX our delivered we For $XXX.X EBITDA momentum revenue $X.X and business. continued adjusted the of third
sales and by service of burn our year-end. of reducing on processed records our lives cash quarter, signing $X year-over-year team report our increased margin, by doubled million healthcare basis agreement support We Health, and sell our base. a strategic we for evidenced $XX the with to hit core account up tracking discussed Elevance existing to partnerships. subsidiary previously KPIs our doesn't channel installed expanding plans million XXX% we've clients with During EBITDA Carelon, and expansion which medical the our across pipeline on the by a and our nearly opportunities I'm as eligible of strategy RFPs, our multi-year executed pleased growth our through that to
gives are and Our XXXX quarter enterprise channels and million the to strength our fund growth. to well all management, financially our quality the well-being third and and continued In focus on With disease channel, engagement, through customers care. of on and very to care optimization, us secure lifestyle pipeline positioned for and we value improved of we sheet, performance access to cost continue balance across our beyond. $XXX delivering confidence three our
adopting a and Sharecare at installed increase Sharecare we've contracts that thousands of As mentioned, integrating to partnership views our Sharecare populations. the and another closing strategic step hundreds contract expanding their as our drive their is are the of for for digital solution, of to took we strategic existing value services large vote ability one with their in of confidence our by multi-year which largest Plus for Plus guide our this engagement is This Carelon. signed to we Together, important deployment Elevance advocacy with health scale member and hope our our speaks partners. for first base members, our in relationship
And case a the our advocacy engagement, and is platform. Sharecare reminder, advocacy Sharecare to solution value deliver designed a utilization is strategic intentional and As addition digital-first Plus as management. and care virtual through clinical benefits very to chronic comprehensive navigation,
advanced systems, clinical network. to data capabilities high CareLinx care with our clinical, cost our and touch through We care analytics in longitudinal in-home telephonic aggregate to utilizing models digital care and invest of continue health with deliver connectivity
out of our on recent to Dr. June our a teams, XXXX. including neuroscientists Sharecare’s new and Sharecare out which to ecosystem, is in of of Jud Officer, programs. our appointment continue digital recruiting build also digital investing invest Dr. We Jud the Chief therapeutic our the Related build Co-Founder retaining Brewer, acquired including Medical that, ecosystem. to renowned psychiatrist, talent MindSciences, in and in clinically we of continue validated leading therapeutics
and shift groups benefits among advocacy a to family see payer We consultants. medium and large also clinical employer towards agnostic
advocacy from Plus and We in continue Further role downside with of And have to space to light team an Sharecare cost remains a macro our satisfaction. benefits to risk Sharecare a play be the one with higher collaborate Elevance’s current quality care. joint perspective, of ability upside continues that solutions the associated labor in the the environment, navigation of important solution priorities the into on with increasing national we moves can health tight. and found to customers. to retention Talent take our and multi-payer of financial employers digital-first employee the market offer accounts PMPMs top
we in increased to continue for as cost see and we Even uncertainty demand advocacy these markets anticipate may the value solutions. efficient persist, will added
actionable Sharecare’s and deliver well-being improve we ROI, high Additionally, insights, proprietary analytics our cost ability leverage can well-being of yield longitudinal with overall data to community the employees precision they benefits. employers alongside optimize helping data and
Sharecare these The helping recognizing than market assembled that parts. more The While the the and its seeing is strategic collective about advocacy. sum last well are Sharecare market the greater is Plus we momentum with of total we is have than market. efforts at the decade over are value resonate capabilities dynamics
within for new as put, strong platform, to they're impactful ease onboarding health. the vendor fatigue for giving with the capabilities demand for deliver as positioned time, experience that implementation, for clinical whether population solutions advocacy benefit platform the uniquely an are for the managers first of comprehensive available. looking member such facing Our continue entire the that the is introducing number point home we we to is yielding of Sharecare interoperable overwhelming believe, solve Simply
In strength health with in with Carelon, we've during addition home the Plus to Sharecare quarter in diversified growth our our channel agreement experienced enterprise offering.
quarter marks our us markets acquired capabilities our of new beyond. Advantage continue expand has achieving To-date, as CareLinx, XXX,XXX to serve and results datasets customers. medicare plan, asset, and for in to very we we the been targets to government that from opening and and this over expanding look to members which our we Advantage we successful and the X.X excellent offer employer, to exceeding to anniversary customers. have the supplemental benefit CareLinx the we health This acquisition both and delivered one-year we Medicare market grown in has million, Medicare Since provider expect XXXX of
engagement. for We capabilities successfully integrated offering, CareLinx have our increasing our core advocacy into precision
in rates. in company's channel to We care XX% very continue This history And expansion to deliver the this optimize CareLinx’s an of and margins. clinical increase well. through to in to capabilities our with Provider, reduce services services, cost readmission revenue, in of invest is expand quality, $XX an transitional high million was year-over-year care performing the quarter largest and
are of globalizing by processes and working workforce. automating additional on We margin our a portion expansion driving
maintained for industry, than buying worth compared the channel spending year. well, saw also to macro continue quarter. and Officer more an has fewer quarter DTC brands can the the the rest the as also to higher pharma new decisions. we and direction from in also beyond. prior for year will we as XXXX Dynamics XX%, our year. even our very driving reduced making robust Panyadahundi, July business that Despite what as grow number XXXX yield challenging Sciences ecosystem see, XXXX, Life Science expertise our about down the and pharma It's a who quarter renewals, performed noting million brands through media brand in to Sharecare grown is the to that third the clients year, an quarter. promotional processed DTC. $X Life hired in to last in through of impact that XX throughout achieve a we pharma and Channel forefront to environment. and third strive payer saw being The in and We're has seeing our XX% note suite indications. margins was July a And continue we important metrics product compared Chief in of Harsha we're success Sciences, we the look spend and the historically year-over-year has the organically Harsha Like Technology supported, will retention new to confident over extensive of solid growth year. especially the pharma already According performance records headwinds, It from keep for in that which top from Life for in is provider In trend growing record we'll at seeing we're to others particularly data was IQVIA's XXXX, continuing client efficiencies optimistic positive drive
the that Additionally, and Omix by on proprietary data research in of Smart academic important XXXX platform, of code equity studies realized continuum. our healthcare plays next recently researchers, our in assets the world empowering talent clinical opportunity and broadens capitalizing real institutions to Smart commercialization, independently. AI acquisition, Sciences point only collection clinicians research generation also enabled the of not but and beyond creation integrity role Doc relevance, Sharecare conduct through data across enables scope and introduced digitally the the expanding no By its and capabilities, Life digital Omix’s Sharecare an solution advancing biomarker
and efficiencies in to Given to bring continue capabilities engaging to will we our pharma customers. for invest non-pharma consumers, clinical research expertise our in
review, evaluate strategic value. to potential actively shareholder discussed continue previously number our opportunities Regarding enhance of we to a
around commenting potential remains a disclosure comes, of is seen or appropriate. we excitement have but array won't and unless necessary there We Sharecare, be an so additional of further until lot
$XX million our in still buyback we Additionally, have program. stock available
our far of I accomplished use assets, belief to positioned to drive we've achieve sheet the the proud for continue that With this future and well I'm well. of year growth in value future and we of feel will of alternative value our goals. shareholders our evaluate we as so are what to strength balance our our incredibly
XXXX. me to Justin, quarter the turn for review of the results some fiscal let share who our and over will commentary call the Now additional remainder regarding financial
